Study of Different Systems for Interpreting Results of Genotypic Antiretroviral Drug Resistance Tests

Shafer R. , & Schapiro J. Interpreting genotypic resistance tests. Published on HIVresistanceWeb: March 4, 2002.

Shafer R.W. , Gonzales M.J. , & Brun-Vezinet F. Online comparison of HV-1 drug resistance algorithms identifies rates and causes of discordant interpretations. Antiviral Therapy 2001; 6(Suppl. 1): 134.

Lanier E.R. , Scott J. , Ait-Khaled M. , Stone C. , Melby T. , Sturge G. , St Clai M.H. , Steel H. , Hetherington S. , Pearce G. , Spreen W. , & Lafon S. Predicting abacavir antiviral activity using HIV-1 reverse transcriptase genotype: a comparison of 12 algorithms. Antiviral Therapy 2001; 6(Suppl. 1): 137.

Beerewinkel N. , Scmidt B. , Walter H. , Kaiser K. , Lengauerl T. , Hoffman D. , Korn K. , & Selbing J. Diversity and complexity of HIV-1 drug resistance: a bioinformatics approach to predicting phenotype from genotype. Proceedings of the National Academy of Sciences, USA 2002; 99: 8271–8276.

Schapiro J.M. Resistance assay interpretation systems vary widely in method and approach. Antiviral Therapy 2001; 6(Suppl. 1): 131.

Kijak G.H. , Rubio A.E. , Pampuro S.E. , Zala C. , Cahn P. , Galli R. , Montaner J.S. , & Salomon H. Discrepant results in the interpretation of HIV-1 drug-resistance genotypic data among widely used algorithms. HIV Medicine 2003 4(1): 72–78.

Puchhammer-Stöckl E. , Steininger C. , Geringer E. , & Heinz F.X. Comparison of virtual phenotype and HIV-SEQ program (Stanford) interpretation for predicting drug resistance of HIV strains. HIV Medicine 2002; 3: 200–206.